Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
96studies shown
Showing 73-84 of 96
Drug study icon
CompletedEUCTR 2008-000679-90

A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Drug study icon
CompletedEUCTR 2012-000517-37

A pilot study of Concerta XL in adult offenders with ADHD

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
ADHD
Drug study icon
CompletedEUCTR 2008-001767-11

A Randomized, Controlled, Open-Label Comparison Study of the Efficacy and Safety of Slow Transitioning compared with Fast Transitioning from a Stimulant Medication to Atomoxetine in Pediatric and A...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom, Portugal, Spain
Sponsor
Eli Lilly and Company Limited
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2006-005512-27

A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperac...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
Not recruitingEUCTR 2010-018579-12

A Phase 3, Randomised, Double-blind, Multicentre, Parallel-group, Placebo- and Active-reference, Dose-optimisation Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France, United Kingdom, Austria, ...
Sponsor
Shire Pharmaceutical Development Ltd
Condition
ADHD
Behavioral study icon
CompletedNCT05518435

Managing Young People With ADHD in Primary Care Study

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralOver 16 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
ADHD
Other study type icon
CompletedNCT05155696

Probiotic Supplementation in Children With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 8 Years to 13 Years
Countries
United Kingdom
Sponsor
St. Mary's University, Twickenham
Condition
ADHD
Other study type icon
Not recruitingISRCTN69461593

QbTest Utility for Optimising Treatment in ADHD (QUOTA)

This study is looking at whether Following consent into trial by a health care professional, the participant will be randomised by a health professional can help people with Specialty: Mental health, Primary sub-specialty: Learning disorders - ADHD, UKCRC code/ Disease: Mental Health/ Behavioural and emotional disorders with onset usually occurring in childhood and adolescence, or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 18 Years to 17 Years
Countries
United Kingdom
Sponsor
Nottinghamshire Healthcare NHS Foundation Trust
Condition
ADHD
Behavioral study icon
CompletedNCT06691646

RECOGNeyes Gaze-Control Training

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 18 Years to 30 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.